ApyraVax is a live attenuated oral vaccine platform eliciting highly effective mucosal secretory IgA responses against enteric pathogens. The first application is a vaccine for Clostridioides difficile infection.
ApyraMed is a biotherapeutic with indications as immune modulator in cancer and beneficial for the gut ecosystem.
Conditioning the gut ecosystem for disease prevention and therapy
Eliciting protective mucosal immune responses
Enhancing immune system competence
Equilibrating the intestinal microbiota in diseases
We develop live biotherapeutics with multiple human and animal health indications due to adaptive modulation of the gut ecosystem
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.